| Literature DB >> 29677490 |
Jong-Ho Lee1, Rui Liu2, Jing Li2, Yugang Wang1, Lin Tan3, Xin-Jian Li1, Xu Qian1, Chuanbao Zhang4, Yan Xia1, Daqian Xu1, Wei Guo5, Zhiyong Ding5, Linyong Du1, Yanhua Zheng1, Qianming Chen6, Philip L Lorenzi3, Gordon B Mills5, Tao Jiang4, Zhimin Lu7.
Abstract
EGFR activates phosphatidylinositide 3-kinase (PI3K), but the mechanism underlying this activation is not completely understood. We demonstrated here that EGFR activation resulted in lysine acetyltransferase 5 (KAT5)-mediated K395 acetylation of the platelet isoform of phosphofructokinase 1 (PFKP) and subsequent translocation of PFKP to the plasma membrane, where the PFKP was phosphorylated at Y64 by EGFR. Phosphorylated PFKP binds to the N-terminal SH2 domain of p85α, which is distinct from binding of Gab1 to the C-terminal SH2 domain of p85α, and recruited p85α to the plasma membrane resulting in PI3K activation. PI3K-dependent AKT activation results in enhanced phosphofructokinase 2 (PFK2) phosphorylation and production of fructose-2,6-bisphosphate, which in turn promotes PFK1 activation. PFKP Y64 phosphorylation-enhanced PI3K/AKT-dependent PFK1 activation and GLUT1 expression promoted the Warburg effect, tumor cell proliferation, and brain tumorigenesis. These findings underscore the instrumental role of PFKP in PI3K activation and enhanced glycolysis through PI3K/AKT-dependent positive-feedback regulation. Published by Elsevier Inc.Entities:
Keywords: EGFR; PFKP; PI3K; phosphorylation; the Warburg effect
Mesh:
Substances:
Year: 2018 PMID: 29677490 PMCID: PMC6114939 DOI: 10.1016/j.molcel.2018.03.018
Source DB: PubMed Journal: Mol Cell ISSN: 1097-2765 Impact factor: 17.970